Kailera Therapeutics

Money present

Biotech

A new benchmark for biotech IPOs? Kailera raises $625M

Kailera appears to have set a new benchmark for biotech IPOs with an upsized $625 million offering to fund its pipeline of obesity therapies.

James Waldron Apr 17, 2026 4:42am

Injectable obesity weight loss

Kailera plans $528.5 million IPO to support obesity assets

Apr 13, 2026 1:10pm

Measuring tape on top of cash

Kailera plots IPO to fund Hengrui-licensed obesity pipeline

Mar 30, 2026 3:45am

cash money

Biotech's top money raisers: 2025

Mar 2, 2026 6:30am

Soccer goal ball score

PitchBook expects disciplined biopharma VC recovery in 2026

Feb 16, 2026 12:01am

obesity pill

Kailera, Hengrui to advance oral obesity drug into 2 new trials

Feb 10, 2026 9:25am